These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 31973625)

  • 1. Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability.
    Koshy L; Harikrishnan S; Sudhakaran PR
    Pharmacogenomics; 2020 Mar; 21(4):257-267. PubMed ID: 31973625
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey.
    Kocael A; Eronat AP; Tüzüner MB; Ekmekçi A; Orhan AL; İkizceli İ; Yılmaz-Aydoğan H; Öztürk O
    Mol Biol Rep; 2019 Apr; 46(2):1825-1833. PubMed ID: 30712247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
    Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
    J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
    Takeuchi M; Kobayashi T; Brandão LR; Ito S
    Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gene polymorphims on the warfarin treatment at initial stage.
    Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
    Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.
    Alrashid MH; Al-Serri A; Alshemmari SH; Koshi P; Al-Bustan SA
    Mol Diagn Ther; 2016 Apr; 20(2):183-90. PubMed ID: 26940072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans.
    Ranasinghe P; Sirisena N; Senadeera V; Anandagoda G; Dissanayake VH
    Pharmacogenomics; 2022 Nov; 23(17):917-923. PubMed ID: 36285665
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH; Chang BC; Lee KE; Gwak HS
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes.
    Ciccacci C; Rufini S; Politi C; Novelli G; Forte V; Borgiani P
    Thromb Res; 2015 Aug; 136(2):367-70. PubMed ID: 26113018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
    Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
    J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.
    Kudzi W; Ahorhorlu SY; Dzudzor B; Olayemi E; Nartey ET; Asmah RH
    BMC Res Notes; 2016 Dec; 9(1):507. PubMed ID: 27938396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
    Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
    Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.
    Asiimwe IG; Zhang EJ; Osanlou R; Krause A; Dillon C; Suarez-Kurtz G; Zhang H; Perini JA; Renta JY; Duconge J; Cavallari LH; Marcatto LR; Beasly MT; Perera MA; Limdi NA; Santos PCJL; Kimmel SE; Lubitz SA; Scott SA; Kawai VK; Jorgensen AL; Pirmohamed M
    Clin Pharmacol Ther; 2020 Jun; 107(6):1420-1433. PubMed ID: 31869433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
    Farzamikia N; Sakhinia E; Afrasiabirad A
    Lab Med; 2017 Dec; 49(1):25-34. PubMed ID: 29182754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.
    Liu N; Irvin MR; Zhi D; Patki A; Beasley TM; Nickerson DA; Hill CE; Chen J; Kimmel SE; Limdi NA
    Pharmacogenomics; 2017 Jul; 18(11):1059-1073. PubMed ID: 28686080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin dosage response related pharmacogenetics in Chinese population.
    Li S; Zou Y; Wang X; Huang X; Sun Y; Wang Y; Dong L; Jiang H
    PLoS One; 2015; 10(1):e0116463. PubMed ID: 25594941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
    Zhuang W; Wu D; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):13-7. PubMed ID: 24602724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Verification of accuracy of warfarin stable dose prediction models in Shandong population].
    Ge Y; Qu F; Wang S; Guo X; Wang C; Liu S; Ma A; Jiang X; Tan K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):401-404. PubMed ID: 32219822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements.
    Ross KA; Bigham AW; Edwards M; Gozdzik A; Suarez-Kurtz G; Parra EJ
    J Hum Genet; 2010 Sep; 55(9):582-9. PubMed ID: 20555338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.